What can be expected from the Drug Delivery Technologies Market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2028, assessing data, trends, opportunities and prospects.
Our 188 page report provides 118 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales across all the major regional and national drug delivery technologies market. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.
Forecasts from 2018-2028 and other analyses show you commercial prospects
Besides revenue forecasting to 2028, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT analysis) and commercial developments.
See revenue forecasts for the leading regional and national markets
How will leading national and regional markets perform to 2028? Our study forecasts revenues in national markets, including:
• US
• EU5 (Germany, France, UK, Spain and Italy)
• Japan
• China
• India
• Brazil
• Russia
• South Korea
• Mexico
• Rest of the World
Leading companies and potential for market growth
Visiongain forecasts overall revenue for the Drug Delivery Technologies Market will reach $217.7bn in 2018. We predict high revenue growth over the forecast period driven by big pharma seeking diversification of their top-selling products and a growing demand for more patient-friendly treatments in healthcare.
Our work analyses the key companies in the market. See visiongain’s analysis of ten leading companies, including:
• Alkermes
• 3M
• Skyepharma
• Becton Dickinson and Company (BD)
• Antares Pharma
• pSivida
• Applied Pharma Research (APR)
• Ethypharm
• Glycologic
• NanoPass Technologies
A company profile gives you the following information where available:
• Discussion of a company’s activities and outlook including regional and national revenue shares
• Historic revenue, analysis and discussion of company performance
• Analysis of major products/services currently available on the market
• Acquisitions and strategic partnerships
Discover capabilities, progress, and commercial prospects, helping you stay ahead.
What issues will affect the drug delivery technologies industry?
Our new report discusses issues and events affecting the drug delivery technologies market. You will find discussions, including qualitative analyses:
• Highly fragmented and competitive market with significant variations in different geographic regions
• Changing political and regulatory landscape changing the prospects of future products and reimbursement opportunities
• Future opportunities for drug delivery technologies
You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.
How the Drug Delivery Technologies Market Analysis : Analysis of Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular and Nasal/Buccal Drug Delivery Technologies; Forecasts for Biologics, Vaccines and Major National Markets and Assessment of Leading Drug Delivery Companies report helps you
In summary, our 189-page report gives you the following knowledge:
• Revenue forecasts to 2028 for the Drug Delivery Technologies market – discover the industry’s prospects, finding promising places for investments and revenues
• Revenue forecasts to 2028 for three major regional markets – US, EU5 and Rest of the World
• Revenue forecasts to 2028 for the leading national markets – US, Germany, France, UK, Spain, Italy, Japan, China, India, Brazil, Russia, South Korea, Mexico and Rest of the World
• Assessment of leading companies – analysis of services, business operations, revenue (where available) and mergers & acquisitions
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market
You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunities. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain’s study is for everybody needing commercial analyses for the drug delivery technologies market and leading companies. You will find data, trends and predictions. Please order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 Global Drug Delivery Technology Market Overview
1.2 Global Drug Delivery Technologies Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who Is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Drug Delivery Technologies: An Introduction
2.1 Drug Delivery Technologies: Strategies to Improve Existing Drugs
2.2 The Global Drug Delivery Technology Market: Methods of Administration
2.2.1 The Biopharmaceutics Classification System and Using Better Tools to Model Drug Absorption
2.2.2 Sustained/Controlled Release Systems
2.2.3 Oral Drug Delivery: Swallowing Drugs to Reach a Target
2.2.4 Pulmonary Delivery: Delivered by Inhalation
2.2.5 Injection as a Route of Drug Delivery
2.2.6 Transdermal Delivery: More Patient-Friendly
2.2.7 Various Transmucosal Delivery Routes for Delivery
2.2.8 Ocular Delivery: Overcoming Unique Barriers
2.3 Regulation in the US
2.3.1 Regulation of Combination Products
2.3.2 FDA Guidelines for Injectors
2.4 Biopharmaceuticals
2.4.1 An Introduction to the Biological Drugs Market
2.4.2 Biologics: A Rising Drugs Market
2.4.3 Biologics with Associated Drug Delivery Technologies
2.4.4 PEGylated Interferons
2.4.5 Stiff Competition in Insulin Market Stimulating Investment in Drug Delivery Technologies
2.4.6 The Main Challenges Facing Biological Drug Delivery
2.5 Market Definition
3. Drug Delivery Technology: Global Market 2018-2028
3.1 The Global Drug Delivery Technology Market in 2017
3.2 The Global Drug Delivery Technology Market Forecast 2018-2028
3.3 Drug Delivery Technology: Drivers and Restraints 2018-2028
3.4 Biologics: A Driver for Growth in Drug Delivery Technologies
3.4.1 The Global Biological Drugs Market Forecast
3.4.2 Leading Classes of Biological Drugs
3.4.3 Monoclonal Antibodies: Largest Sector in Biologics
3.4.4 Human insulin: Leading the Therapeutic Protein Segment
3.4.5 Interferon Products for the Treatment of Hepatitis
3.5 Vaccines: Meeting the Unmet Needs
3.5.1 The Global Vaccines Market Forecast
4. Drug Delivery Technologies: Submarkets 2018-2028
4.1 The Global Drug Delivery Technology Market by Submarkets
4.2 How Will Segmental Market Shares Change to 2028?
4.3 Oral Drug Delivery Technology
4.3.1 Oral Drug Delivery Technology Market Forecast 2018-2028
4.3.2 Trends and Developments
4.3.3 Oral Drug Delivery Technologies: Drivers and Restraints 2018-2028
4.4 Inhalable Drug Delivery Technology
4.4.1 Inhalable Drug Delivery Technology Market Forecast 2018-2028
4.4.2 Trends and Developments
4.4.3 Inhalable Drug Delivery Technologies: Drivers and Restraints 2018-2028
4.5 Injectable/Implantable Delivery Technology
4.5.1 Injectable/Implantable Delivery Technology Market Forecast 2018-2028
4.5.2 Trends and Developments
4.5.3 Injectable/Implantable Delivery Technologies: Drivers and Restraints 2018-2028
4.6 Transdermal Drug Delivery Technology
4.6.1 Transdermal Drug Delivery Technology Market Forecast 2018-2028
4.6.2 Trends and Developments
4.7 Ocular Drug Delivery Technology
4.7.1 Ocular Drug Delivery Technology Market Forecast 2018-2028
4.7.2 Trends and Developments
4.8 Nasal/Buccal Drug Delivery Technology
4.8.1 Nasal/Buccal Drug Delivery Technology Market Forecast 2018-2028
4.8.2 Trends and Developments
5. Drug Delivery Technologies: Leading National Markets 2018-2028
5.1 Global Drug Delivery Technology Market: Regional Forecast 2018-2028
5.1.1 How Will Regional Market Shares Change to 2028?
5.2 US Drug Delivery Technology Market 2018-2028
5.2.1 US Drug Delivery Technology Market Forecast 2018-2028
5.2.2 Eli Lilly to Establish Drug Delivery Centre
5.3 EU5 Drug Delivery Technology Market 2018-2028
5.3.1 EU5 Drug Delivery Technology Market Forecast 2018-2028
5.3.2 EU5 Drug Delivery Technologies Market: CAGR (%) by Country, 2018-2028
5.3.3 EU5 Markets: Changing Market Shares by Country, 2018-2028
5.3.4 The German Drug Delivery Technology Market Forecast 2018-2028
5.3.5 The French Drug Delivery Technology Market Forecast 2018-2028
5.3.6 The UK Drug Delivery Technology Market Forecast 2018-2028
5.3.7 The Spanish Drug Delivery Technology Market Forecast 2018-2028
5.3.8 The Italian Drug Delivery Technology Market Forecast 2018-2028
5.4 Japanese Drug Delivery Technology Market 2018-2028
5.4.1 Japanese Drug Delivery Technology Market Forecast 2018-2028
5.4.2 The New Sakigake Designation System May Accelerate Innovative Drug Development
5.5 Chinese Drug Delivery Technology Market 2018-2028
5.5.1 Chinese Drug Delivery Technology Market Forecast 2018-2028
5.6 Indian Drug Delivery Technology Market 2018-2028
5.6.1 Indian Drug Delivery Technology Market Forecast 2018-2028
5.7 Brazilian Drug Delivery Technology Market 2018-2028
5.7.1 Brazilian Drug Delivery Technology Market Forecast 2018-2028
5.8 Russian Drug Delivery Technology Market 2018-2028
5.8.1 Russian Drug Delivery Technology Market Forecast 2018-2028
5.9 South Korean Drug Delivery Technology Market 2018-2028
5.9.1 South Korean Drug Delivery Technology Market Forecast 2018-2028
5.10 Mexican Drug Delivery Technology Market 2018-2028
5.10.1 Mexican Drug Delivery Technology Market Forecast 2018-2028
5.11 Rest of the World Drug Delivery Technology Market Forecast 2018-2028
6. Leading Companies in the Drug Delivery Technology Market 2017
6.1 Alkermes: Focused on Extended and Controlled Release
6.1.1 Alkermes PLC
6.1.2 Alkermes PLC: Company Overview
6.1.3 Alkermes PLC: Recent Developments
6.2 3M
6.2.1 3M: Company Overview
6.2.2 3M Company: Product Portfolio
6.2.3 3M Company: Recent Developments
6.3 Becton, Dickinson & Company: A History of Hypodermic Needles and Syringes
6.3.1 Becton, Dickinson & Company: Company Overview
6.3.2 Becton, Dickinson & Company: Recent Developments
6.4 Intercell AG
6.4.1 Intercell AG: Company Overview
6.5 Altea Therapeutics Corporation
6.5.1 Altea Therapeutics Corporation: Company Overview
6.6 Antares Pharma: Leading the Needle-Free Injector Market
6.6.1 Antares PharmaInc.: Company Overview
6.6.2 Antares Pharma Inc.: Recent Developments
6.7 pSivida:
6.7.1 pSivida Corporation: Company Overview
6.7.2 pSivida Corporation: Recent Developments
6.8 Applied Pharma Research (APR)
6.8.1 Applied Pharma Research S.A.: Company Overview
6.8.2 Applied Pharma Research S.A.: Recent Developments
6.9 Ethypharm
6.9.1 Ethypharm S.A.: Company Overview
6.10 Glycologic
6.10.1 Glycologic Limited: Company Overview
6.11 NanoPass Technologies
6.11.1 NanoPass Technologies Ltd.: Company Overview
6.11.2 NanoPass Technologies Ltd.: Recent Developments
7. Qualitative Analysis of the Drug Delivery Technology Market 2018-2028
7.1 SWOT Analysis of the Drug Delivery Technology Market
7.2 Strengths
7.2.1 Increasing Competition and Patent Expiry in the Biologics Market
7.2.2 The Rise of Biosimilars
7.2.3 Increasing Global Diabetic Population
7.3 Weaknesses
7.3.1 Risk-Conscious Regulatory Bodies Will Make Approval Difficult
7.3.2 Companies Need to Develop a More Liberal Mindset
7.4 Opportunities
7.4.1 Nanotechnology: Innovations That Will Benefit Drug Delivery
7.4.2 Possible New Delivery Methods for Insulin
7.5 Threats
7.5.1 Increasing Specificity of Drug Development Poses Challenges to Speciality Drug Delivery Companies
7.5.2 Cost Effective Solutions May Not Be Available
8. Conclusions
8.1 The Global Drug Delivery Technologies Market in 2018
8.1.1 Current Leading Drug Delivery Technology Segments
8.1.2 Notable Drug Delivery Technology Companies
8.1.3 Leading Regional/National Markets
8.2 Global Drug Delivery Technology Market Forecast 2018-2028
8.3 The Future of the Drug Delivery Technology Market
8.3.1 Transdermal and Injectable Drug Delivery Technologies Set For High Growth
8.3.2 Biologics and Biosimilars to Drive Market Growth
9. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
List of Figures
Figure 1.1 Global Drug Delivery Technologies Market Segmentation Overview 2018
Figure 3.1 The Global Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 3.2 Drug Delivery Technologies: Market Drivers and Restraints 2018-2028
Figure 3.3 Global Biological Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 3.4 Global Vaccines Market: Revenues ($bn) and AGR (%), 2018-2028
Figure 4.1 Leading Drug Delivery Market Segments: CAGR (%), 2018-2022
Figure 4.2 Leading Drug Delivery Market Segments: CAGR (%), 2022-2028
Figure 4.3 Leading Drug Delivery Market Segments: CAGR (%), 2018-2028
Figure 4.4 Market Shares (%) of Leading Drug Delivery Market Segments, 2017
Figure 4.5 Market Shares (%) of Leading Drug Delivery Market Segments, 2022
Figure 4.6 Market Shares (%) of Leading Drug Delivery Market Segments, 2028
Figure 4.7 Oral Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 4.8 Oral Drug Delivery Technologies: Drivers and Restraints 2018-2028
Figure 4.9 Inhalable Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 4.10 Inhalable Drug Delivery Technologies: Drivers and Restraints 2018-2028
Figure 4.11 Injectable/Implantable Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 4.12 Injectable/implantable Drug Delivery Technologies: Drivers and Restraints 2018-2028
Figure 4.13 Transdermal Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 4.14 Ocular Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 4.15 Nasal/Buccal Drug Delivery Technology Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.1 The Global Drug Delivery Technologies Market by Country/Region: Revenue ($bn), 2018
Figure 5.2 Global Drug Delivery Technology Market: Revenue ($bn) by Country/Region, 2018, 2022 and 2028
Figure 5.3 Global Drug Delivery Technology Market: CAGR (%) by Country/Region, 2018-2022
Figure 5.4 Global Drug Delivery Technology Market: CAGR (%) by Country/Region, 2022-2028
Figure 5.5 Global Drug Delivery Technology Market: CAGR (%) by Country/Region 2018-2028
Figure 5.6 Global Drug Delivery Technology Market: Market Share (%) by Country/Region, 2017
Figure 5.7 Global Drug Delivery Technology Market: Market Share (%) by Country/Region, 2022
Figure 5.8 Global Drug Delivery Technology Market: Market Share (%) by Country/Region, 2028
Figure 5.9 US Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.10 EU5 Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.11 EU5 Drug Delivery Technology Market: CAGR (%) by Country, 2018-2022
Figure 5.12 EU5 Drug Delivery Technology Market: by Country, 2022-2028
Figure 5.13 EU5 Drug Delivery Technology Market: CAGR (%) by Country, 2018-2028
Figure 5.14 EU5 Drug Delivery Technology Market: Market Share (%) by Country, 2017
Figure 5.15 EU5 Drug Delivery Technology Market: Market Share (%) by Country, 2022
Figure 5.16 EU5 Drug Delivery Technology Market: Market Share (%) by Country, 2028
Figure 5.17 German Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.18 French Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.19 UK Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.20 Spanish Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.21 Italian Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.22 Japanese Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.23 Chinese Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.24 Indian Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.25 Brazilian Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.26 Russian Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.27 South Korean Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.28 Mexican Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.29 Rest of the World Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
Figure 6.1 Alkermes PLC, Revenue, ($million), 2012-2016
Figure 6.2 Alkermes PLC, Geographical Presence Share (%), 2016
Figure 6.3 3M, Revenue, ($million), 2012-2016
Figure 6.4 3M, Product Segments Share (%), 2016
Figure 6.5 3M, Geographical Presence Share (%), 2016
Figure 6.6 Becton, Dickinson & Company, Revenue, ($million), 2013-2017
Figure 6.7 Becton, Dickinson & Company, Geographical Presence Share (%), 2017
Figure 6.8 Becton, Dickinson & Company, Segment Share (%), 2017
Figure 6.9 Antares Pharma Inc., Revenue, ($million), 2013-2017
Figure 6.10 6pSivida Corporation, Revenue, ($million), 2012-2016
Figure 6.11 pSivida Corporation, Product Segments Share (%), 2016
Figure 6.12 Ethypharm S.A., Revenue, ($million), 2012-2016
List of Tables
Table 1.1 Global Drug Delivery Technologies Market Forecast: Revenue ($bn), AGR (%) and CAGR (%) by Region, 2018-2028 (Redacted Data)
Table 2.1 The Biopharmaceutics Classification System, Classification and Description
Table 2.2 Top 5 Biologics by Sales ($bn), 2018
Table 3.1 The Global Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 3.2 Global Biological Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 3.3 Global Vaccines Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 4.1 The Global Drug Delivery Technology Market by Submarkets: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 4.2 Leading Drug Delivery Market Segments: Share (%), 2017, 2022, and 2028
Table 4.3 Leading Drug Delivery Market Segments: Market Share (%), 2017
Table 4.4 Oral Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 4.5 Inhalable Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 4.6 Insulin Inhalers Withdrawal from the Market or Pipeline, 2017
Table 4.7 Injectable/Implantable Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 4.8 Transdermal Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 4.9 Ocular Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 4.10 Nasal/Buccal Drug Delivery Technology Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.1 The Global Drug Delivery Technologies Market by Country/Region: Revenue ($bn) and Market Share (%), 2017
Table 5.2 Global Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%) by Country/Region, 2018-2028
Table 5.3 Global Drug Delivery Technology Market: Revenue ($bn) by Country/Region, 2018, 2022 and 2028
Table 5.4 Global Drug Delivery Technology Market: Revenue ($bn) and Market Share (%) by Country/Region, 2017, 2022 and 2028
Table 5.5 US Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.6 EU5 Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.7 EU5 Drug Delivery Technology Market: CAGR (%) by Country, 2018-2022, 2022-2028 and 2018-2028
Table 5.8 EU5 Drug Delivery Technology Market: Market Size ($bn) and Market Share (%) by Country, 2017, 2022 and 2028
Table 5.9 German Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.10 French Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.11 UK Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.12 Spanish Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.13 Italian Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.14 Japanese Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.15 Chinese Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.16 Indian Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.17 Brazilian Drug Delivery Technology Market Forecast: Revenue ($bn) and AGR (%), 2018-2028
Table 5.18 Russian Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.19 South Korean Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.20 Mexican Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.21 Rest of the World Drug Delivery Technology Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 6.1 Akermes PLC: Company Overview
Table 6.2 Alkermes PLC: Recent Developments
Table 6.3 3M: Company Overview
Table 6.4 3M: Product Portfolio
Table 6.5 3M Company: Recent Developments
Table 6.6 Becton, Dickinson & Company: Company Overview
Table 6.7 Becton, Dickinson & Company: Recent Developments
Table 6.8 Intercell AG: Company Overview
Table 6.9 Altea Therapeutics Corporation: Company Overview
Table 6.10 Antares Pharma Inc.: Company Overview
Table 6.11 Antares Pharma Inc.: Recent Developments
Table 6.12 pSivida Corporation: Company Overview
Table 6.13 pSivida Corporation: Recent Developments
Table 6.14 Applied Pharma Research S.A.: Company Overview
Table 6.15 Applied Pharma Research S.A.: Recent Developments
Table 6.16 Ethypharm S.A.: Company Overview
Table 6.17 Glycologic Limited: Company Overview
Table 6.18 NanoPass Technologies Ltd.: Company Overview
Table 6.19 NanoPass Technologies Ltd.: Recent Developments
Table 7.1 SWOT Analysis of the Drug Delivery Technology Market, 2018-2028
3M
Acorda
Actavis
Adamis
Aleza Pharmaceuticals
Alkermes
Almirall
Alza
Antares Pharma
Applied Pharma Research
Aradigm
Astellas
AstraZeneca
Bayer HealthCare Pharmaceuticals
BD
Biogen
BioGeneration Ventures
Bioject Medical Technologies
Boehringer Ingelheim
Bristol¬Myers Squibb
CareFusion Corporation
Cephalon
Changchun BCHT
Chiesi
Chrono Therapeutics
Cilag
Cima Labs
Clearside
Cosmo Pharmaceuticals
CRISI Medical Systems
CTCBIO
Daiichi
Elan Drug Technologies
Elcam Medical
Eli Lilly
Ethypharm
Ferrer
Ferring
Flamel
Genentech
GlaxoSmithKline
Glycologic
Google
GSK
Haselmeir
Horizon Pharma
ImmusanT
Innovent Biologics
Insmed
Invion
iScience Interventional Corporation
J&J
Janssen
JCR Pharmaceuticals
Kyorin
MannKind
Meda Pharmaceuticals
Medac
Medimetrics
MedImmune
MedSciences Capital
Merck Serono
Mucosis
Mundipharma
Nanopass Technologies
Nektar Therapeutics
Nexvax2
NHTherapeutics
Novartis
Novo Nordisk
NuPathe
NV NOM
Oramed
OwenMumford
Pacira Pharmaceuticals
Pari Pharma
Permatec
Pfizer
PharmaJet
Presspart
ProStrakan
pSivida
Pulmagen
Ranbaxy
Rani Therapeutics
Recro Pharma
Regeneron Pharmaceuticals
Roche
Sandoz
Sanofi-Aventis
Santen
Shionogi
SHL Group
Shreya Life Sciences
Skyepharma
Smoofi
Spark Therapeutics
STADA Arzneimittel
Takeda
Teva
UU Holdings
Vetter Pharma
West Pharmaceuticals
Ypsomed
List of Organizations
European Medicines Agency (EMA)
Ministry of Health, Labor and Welfare (MHLW)
The Centers for Disease Control and Prevention (CDC)
The Organisation for Economic Co-operation and Development (OECD)
UK National Health Service (NHS)
US Food & Drug Administration (FDA)
World Health Organisation (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
